Foscarnet
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AD - Phosphonic Acid Derivatives -> J05AD01 - Foscarnet
Administration category:
Free
Medicine group:
antiviral
Brand name:
Foscavir
Safety margins
| Weight | ROA | Dosage |
|---|---|---|
|
ROA: iv |
Dosage: min. 40mg/kg 3 dd to max. 90mg/kg 2 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: iv | ||||
|
GFR: 50 - 80 |
Comments: zie tabel (pdf) |
|||
|
GFR: 20 - 50 |
Comments: zie tabel (pdf) |
|||
|
GFR: 10 - 20 |
Comments: zie tabel (pdf) |
|||
|
GFR: <10 |
Comments: zie tabel (pdf) |
|||
Renal elimination:
80%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: gebruik vermijden
Hemo dialysis: gebruik vermijden
CAV / VVHD: zie link voor dosering: https://amsterdamumc.adult.nl.antibiotica.app/node/501244
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-501293.1
Updated: 12/29/2022 - 12:35
Status: Published
General comments
Doseringsadviezen bij CMV infectie bij hematopoietische stamceltransplantatie (HST) patiënten zijn te vinden in deze PDF.